EMJ Oncology 11 [Supplement 1] . 2023

In this issue

This article reviews key updates on ovarian cancer research that were presented at the European Society for Medical Oncology (ESMO) Congress 2022. Rising global incidence, high relapse rates, and poor prognoses have highlighted the need for improved survival and quality of life for patients with ovarian cancer.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.